Clinical Trial Update: A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI) [NA]

View source ↗

Summary

A recruiting clinical trial evaluating pegmolesatide in dialysis-dependent chronic kidney disease patients with anemia who are treated with a hypoxia-inducible …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Pegmolesatide

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Renal Anemia of Chronic Kidney Disease | NA | Status: RECRUITING